Moldova authorizes new drugs from four countries
Twenty-four new medicines will be available on the pharmaceutical market in the Republic of Moldova. The specialized commission within the Agency for Medicines and Medical Devices (AMDM) decided to authorize an additional 31 medications, seven of which are duplicates.
Among the drugs approved for the first time in the Republic of Moldova are preparations such as antidepressants and drugs for destroying tumor cells, regulating immunity and preventing the formation of blood clots, including an intravenous treatment to replace severe iron deficiency.
List of the most important medicines authorized for the first time:
Revelio (produced in Bulgaria) – is used for the short-term symptomatic treatment of acute pain of mild to moderate intensity (for example: muscle pain, joint pain, menstrual pain - dysmenorrhea, toothache).
Aboxoma (produced in Slovenia) – is an oral anticoagulant that directly blocks a key component of the coagulation process, preventing the formation or worsening of blood clots.
Ferinject (produced in France) – is a preparation with intravenous administration, used for the treatment of iron deficiency when oral supplements are ineffective or cannot be tolerated.
Iberogast Balance oral drops (produced in Romania) – is a herbal medicine for gastrointestinal disorders.
Macronit Macrocristal (produced in the Republic of Moldova) – is an antibacterial agent for systemic use.
Rilmenidine Grindeks (produced in Latvia) – is a medicine that is used to treat high blood pressure in adults.
RHINFANT (produced in Turkey) – is a pediatric nasal medicine used to unclog the nose and reduce mucosal edema in rhinitis, sinusitis and otitis. It contains active substances that contract the blood vessels in the nose, quickly restoring normal breathing.
Erbamadi 8 mg powder and solvent for solution for injection (made in Turkey) – is an anti-inflammatory drug used for the short-term relief of mild to moderate acute pain, especially when oral administration is not possible.
Ciklox (produced in India) – is an antidepressant from the class of selective serotonin reuptake inhibitors.
Neprivas (made in India) – is mainly used to treat high blood pressure, heart failure and chronic kidney disease.
Cinomer (produced in Iran) – is a complex drug used to destroy tumor cells or to regulate the response of the immune system.
Tramadol (produced in Russia) – is a centrally acting opioid analgesic used to treat moderate to severe, acute and chronic pain.
The Republic of Moldova currently produces between 550 and 600 types of medicines, which accounts for approximately 10% of the products listed in the State Nomenclature, totaling over 6,000 authorized items.
In 2025, the pharmaceutical market in Moldova was predominantly supplied by imported medicines, with 93% of products coming from abroad, according to data from the Agency for Medicines and Medical Devices.
Last year, the pharmaceutical market in Moldova generated nearly 866.7 million euros. Imported medicines made up 92.89% of the market's value and 86.22% of the total volume traded. In contrast, local manufacturers accounted for about 13.8% of volume but only 7.1% of market value, suggesting that domestic medicines are generally cheaper.
Among the best-selling imported medicines, based on their international non-proprietary names, are Dapagliflozin (used for type 2 diabetes and heart failure), Ibuprofen (used for pain relief and fever reduction), and Rivaroxaban (used in the prevention and treatment of blood clots, including post-surgery).
For domestically produced medicines, the leading products were Rivaroxaban, followed by Famotidine (used for gastric and duodenal ulcers, reflux esophagitis, and Zollinger-Ellison syndrome) and Bicalutamide (an antiandrogen used to treat advanced prostate cancer).
